Kosaku Murakami

3.4k total citations
123 papers, 1.4k citations indexed

About

Kosaku Murakami is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kosaku Murakami has authored 123 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Rheumatology, 28 papers in Immunology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kosaku Murakami's work include Rheumatoid Arthritis Research and Therapies (43 papers), Systemic Lupus Erythematosus Research (28 papers) and Autoimmune and Inflammatory Disorders Research (17 papers). Kosaku Murakami is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (43 papers), Systemic Lupus Erythematosus Research (28 papers) and Autoimmune and Inflammatory Disorders Research (17 papers). Kosaku Murakami collaborates with scholars based in Japan, United States and United Kingdom. Kosaku Murakami's co-authors include Tsuneyo Mimori, Koichiro Ohmura, Masao Tanaka, Motomu Hashimoto, Hajime Yoshifuji, Ran Nakashima, Hiromu Ito, Koichi Murata, Takashi Usui and Shuichi Matsuda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and The Journal of Immunology.

In The Last Decade

Kosaku Murakami

109 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kosaku Murakami Japan 19 619 370 305 241 226 123 1.4k
Yohei Kirino Japan 26 696 1.1× 346 0.9× 588 1.9× 230 1.0× 291 1.3× 95 1.7k
António Marinho Portugal 22 357 0.6× 429 1.2× 228 0.7× 152 0.6× 180 0.8× 92 1.3k
Takahiko Sugihara Japan 16 488 0.8× 279 0.8× 227 0.7× 142 0.6× 166 0.7× 72 1.0k
Claudia Mendoza‐Pinto Mexico 25 896 1.4× 492 1.3× 188 0.6× 116 0.5× 144 0.6× 100 1.6k
Tiffany Caza United States 23 475 0.8× 667 1.8× 505 1.7× 258 1.1× 90 0.4× 76 2.0k
Hideko Nakahara Japan 10 481 0.8× 330 0.9× 227 0.7× 164 0.7× 286 1.3× 20 1.2k
Floranne C. Ernste United States 21 810 1.3× 390 1.1× 196 0.6× 224 0.9× 138 0.6× 50 1.4k
Mohammed Akil United Kingdom 17 607 1.0× 461 1.2× 251 0.8× 112 0.5× 124 0.5× 45 1.2k
Mathias Grünke Germany 19 674 1.1× 642 1.7× 182 0.6× 121 0.5× 221 1.0× 41 1.4k
Kwi Young Kang South Korea 21 677 1.1× 311 0.8× 247 0.8× 121 0.5× 76 0.3× 66 1.3k

Countries citing papers authored by Kosaku Murakami

Since Specialization
Citations

This map shows the geographic impact of Kosaku Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosaku Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosaku Murakami more than expected).

Fields of papers citing papers by Kosaku Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosaku Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosaku Murakami. The network helps show where Kosaku Murakami may publish in the future.

Co-authorship network of co-authors of Kosaku Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Kosaku Murakami. A scholar is included among the top collaborators of Kosaku Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosaku Murakami. Kosaku Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yoshida, Akiko, Kosaku Murakami, Hirotake Tsukamoto, et al.. (2025). Anti-arthritic effects of polyunsaturated fatty acid–rich supplementation combined with selective soluble epoxide hydrolase inhibitors in a collagen-induced arthritis mouse model. Modern Rheumatology. 35(4). 665–676. 1 indexed citations
4.
Yoshida, Tsuneya, Yuuki Sato, & Kosaku Murakami. (2025). Comment on: NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitors. Lara D. Veeken. 64(11). 6001–6002.
5.
Murakami, Kosaku, Tomonori Yaguchi, Kenji Chamoto, et al.. (2025). ICOS+CD4+ T cells define a high susceptibility to anti–PD-1 therapy–induced lung pathogenesis. JCI Insight. 10(10). 1 indexed citations
6.
Yonezawa, Atsushi, Daiki Hira, Tomohiro Handa, et al.. (2024). Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study. Journal of Pharmaceutical Health Care and Sciences. 10(1). 52–52. 2 indexed citations
7.
Murata, Koichi, Takayuki Fujii, Akira Ōnishi, et al.. (2024). Low Hounsfield unit values on computed tomography as a potential predictor of vertebral fracture in patients with rheumatoid arthritis: The KURAMA cohort study. International Journal of Rheumatic Diseases. 27(4). e15146–e15146. 2 indexed citations
9.
Murakami, Kosaku, Hideo Onizawa, Mirei Shirakashi, et al.. (2023). A case of atypical IgG4-related disease presenting hypereosinophilia, polyneuropathy, and liver dysfunction. Modern Rheumatology Case Reports. 8(1). 172–177.
10.
Iwasaki, Takashi, Ryu Watanabe, Hiromu Ito, et al.. (2023). POS0241 MONOCYTE-DERIVED TRANSCRIPTOMES EXPLAIN THE INEFFECTIVENESS OF ABATACEPT IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 82. 353–354. 1 indexed citations
11.
Ito, Isao, Masao Tanaka, Koichi Murata, et al.. (2023). Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis. Clinical and Experimental Medicine. 23(8). 4707–4720. 2 indexed citations
12.
Watanabe, Ryu, Kosaku Murakami, Hiromu Ito, et al.. (2023). Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort. Immunological Medicine. 46(2). 84–92. 1 indexed citations
13.
Murata, Koichi, Shuji Ito, Akari Suzuki, et al.. (2022). Role of Lysine‐Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia‐Inducible Factor 1α and E2F1. Arthritis & Rheumatology. 74(6). 948–960. 44 indexed citations
14.
Hashimoto, Motomu, Yoshihito Fujita, Kaori Ikeda, et al.. (2021). Urinary sodium-to-potassium ratio associates with hypertension and current disease activity in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Research & Therapy. 23(1). 96–96. 10 indexed citations
16.
Watanabe, Ryu, Motomu Hashimoto, Koichi Murata, et al.. (2021). Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients. Rheumatology International. 42(11). 1983–1991. 5 indexed citations
18.
Ito, Hiromu, Shuichiro Nakabo, Hideaki Tsuji, et al.. (2021). Region specificity of rheumatoid foot symptoms associated with ultrasound-detected synovitis and joint destruction. Modern Rheumatology. 32(1). 127–135. 2 indexed citations
19.
Maeda, Yuichi, Tôru Hirano, Ryota Hara, et al.. (2020). THU0174 ANTI-IL-6 RECEPTOR ANTIBODY AMELIORATES DISEASE ACTIVITY OF RHEUMATOID ARTHRITIS PATIENTS WITH KNEE JOINT INVOLVEMENT -ANSWER COHORT STUDY-. Annals of the Rheumatic Diseases. 79. 302–303. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026